catalyst · primary record
Follitropin alfa/lutropin alfa (MBJ-0011) + hMG + Cetrorelix acetate
Phase readout · 2027-09-30 · Infertility
| Company | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany |
|---|---|
| Ticker | Not stated |
| Impact | high |
| Detail | P3 primary completion · NCT07340827 |
| Source | ClinicalTrials.gov |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:51.299Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany:Follitropin alfa/lutropin alfa (MBJ-0011) + hMG + Cetrorelix acetate:2027-09-30:P3 primary completion · NCT07340827
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.